SCD5 and breast carcinoma: However, the expression of SCD5 was lower in more aggressive metastatic breast cancer and melanoma cells than primary breast cells and low-invasive melanoma [177,216], and supplementation with OA reduced A375M melanoma cell malignancy by reducing the dissemination capability, impairing tumor spread [178].